Thyrocare Technologies Limited BuyBack 2018

Thyrocare Technologies Limited is India’s first and most advanced Totally Automated Laboratory having its strong presence in more than 2000 cities / towns in India and internationally. Thyrocare is India’s first fully automated diagnostic laboratory with a focus on providing quality at affordable costs to laboratories and hospitals in India and other countries.

Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai – India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia. We have focus on strong technologies, strong brands and strong systems that enable all laboratories to give their clients the best of science and technology at an affordable cost.

With a belief that ‘Quality’ is the heart of any intelligent management, Thyrocare became one of the first Indian diagnostic laboratories to obtain internationally renowned quality accreditations like ISO 9001-2000 rating as early as 2001, which is now escalated to ISO 9001:2008 and CAP (College of American Pathologists) certification in 2007.

Company Network
Networks of authorized, trained and equipped collection centers serve through a very strong IT and Logistics. The Company clear focus on speed and accuracy further made us the first Indian laboratory to also have an IT-enabled, 24×7, fully automated diagnostic laboratory set up covering over 2,00,000 sq. ft. floor space that ensures error-free processing of over 50,000 specimens and over 2,00,000 Clinical Chemistry investigations per night. Our unmatched speed factor is achieved through a combination of air-cargo logistics and IT-enabled, barcoded, bi-directional systems that ensures a turnaround time of 4 to 8 hours for processing of samples that arrive at any time of the day or night.

Meticulously created and monitored systems, well-chosen and trained manpower, wise selection of the best global technologies for specialized testing and an uncompromised approach to instrumentation has ensured that Thyrocare is looked upon as a yardstick for quality by stakeholders in the diagnostic industry. The uniqueness of Thyrocare is its effort to innovate and remain at par of the global standards for best of quality service delivery, at the most cost-effective prices.

Many laboratories and hospital brands in India, Middle East, and South East Asian countries, use Thyrocare to complete their menu and deliver quality at an affordable cost.

Our Differentiators
Unique concept – Thyrocare operates with a Centralized Processing Laboratory (CPL) in Mumbai – India for esoteric tests; and Regional Processing Laboratory in major metro cities of India and other parts of Asia.
Unique focus – We focus on clinical chemistry and preventive care diagnosis.
Unique air-cargo logistics – which ensure the samples reach our laboratory every night, same night, before midnight.
Unique operations – Our laboratory works 24 x 7 to cater to the needs of our customers.
Aptio (Siemens)- World’s largest and longest laboratory track automation- 1st Time in India India’s First preanalytical barcoded vial sorter (MUT) and Sample Sorter (Roche).

Buy Back Offer Deal:

Buyback Type: Open Market
Buyback Opening Date: Sep 24 2018
Buyback Closing Date: Oct 25 2018
Buyback Offer Amount: ₹ 63 Cr
Date of Board Meeting approving the proposal: Aug 04 2018
Date of Public Announcement: Sep 07 2018
Buyback Offer Size: 1.61%
Buyback Number of Shares: 8.83 Lakhs
FV: 10
Buyback Price: ₹ 730 Per Equity Share

Details of Buyback:

Thyrocare Technologies Ltd (BSE: 539871 | NSE: THYROCARE) board has approved a proposal for buyback of up to 8.83 Lakhs shares at Rs 730 per share, aggregating Rs 63 cr which is 1.61% of total number of paid-up equity shares capital. The Company is buying stocks from Open Market, so no Record date is going to publish.

How to Participate in buyback?

Thyrocare Technologies Limited BuyBack is an Open Market BuyBack In this method of share buyback, the company buys its own stocks from the market. This transaction happens through the company’s brokers. This repurchase program happens for an extended period of time as a large block of shares needs to be bought. The company is under no obligation to conduct the repurchase program after the announcement. The company has the option to cancel it. Also, it can make changes in the repurchase program according to company’s situations and needs. If this method is effectively implemented, it can prove to be very cost effective.


Review and Recommendation of Thyrocare Technologies Limited BuyBack 2018 from InvestorZone Team is: Rating: Avoid Thyrocare Technologies Limited BuyBack shares on the open market over an extended period of time.

Company Contact Details:

Thyrocare Technologies Limited Address: D-37/1, MIDC, Turbhe, Opp. Sandoz, Navi Mumbai - 400 703 Phone: (+91)22 - 4125 2525 / (+91)22 - 3090 0000 Fax:(+91)22 - 2768 2409 Email:


    Buy back of Thyrocare already started w.e.f. 24.08.2018 but till date neither I have received any buy back form, my eligibility etc. I am having HDFC Dmat account in which no such details of buy back is available. Please advise what is the procedure to render shares of Thyrocare for Buy back as on today

      It is an open market buyback, not a tender buyback. In this buyback, the company buys back shares from the open market rate. So no gain as such for investors.

    Promoters not to participate in buyback. May need maximum of Rs 25-30 cr funds for nuclear business, says Dr A Velumani of @Thyrocare

      Thyrocare BuyBack 2018
      Open market so from buyback point of view..Thyrocare is an avoid

Leave a Reply